To examine whether gout is an independent risk factor for total joint replacement (TJR) and whether urate-lowering treatment (ULT) reduces this risk.Using the Taiwan National Health Insurance database and the UK Clinical Practice Research Datalink, 74 560 Taiwan patients and 34 505 UK patients with incident gout were identified and age and sex matched to people without gout. Cox proportional hazards models and condition logistic regression were used to examine the risk of TJR in gout patients and the association between cumulative defined daily dose (cDDD) of ULT and TJR.The prevalence rates of TJR in the patients at the time of diagnosis of gout and in people without gout were 1.16% vs 0.82% in Taiwan and 2.61% vs 1.76% in the UK. After a gout diagnosis, the incidence of TJR was higher in the patients with gout compared with those without (3.23 vs 1.91 cases/1000 person-years in Taiwan and 6.87 vs 4.61 cases/1000 person-years in the UK), with adjusted HRs of 1.56 (95% CI 1.45, 1.68) in Taiwan and 1.14 (1.05, 1.22) in the UK. Compared with patients with gout with <28 cDDD ULT, the adjusted ORs for TJR were 0.89 (95% CI 0.77, 1.03) for 28-90 cDDD, 1.03 (0.85, 1.24) for 90-180 cDDD and 1.12 (0.94, 1.34) for >180 cDDD ULT in Taiwan. In the UK, the respective ORs were 1.09 (0.83, 1.42), 0.93 (0.68, 1.27) and 1.08 (0.94, 1.24).This population-based study provides evidence from two nation populations that gout confers significant TJR risk, which was not reduced by current ULT.
In recent years, there has been a rapid worldwide emergence of multidrugresistant (MDR) pathogens, especially in cases of nosocomial infections. This study assesses the in vitro activities of ampicillin/sulbactam, cefpirome, colistin, daptomycin, ertapenem, meropenem, teicoplanin, tigecycline and vancomycin against 208 aerobic bacterial pathogens that caused 197 nosocomial infections in 184 patients.Antimicrobial susceptibility was evaluated by Etest. Broth dilution method was utilized in tigecycline susceptibility testing.Most (140/208, 67%) of the isolates were facultative Gram-negative bacilli. Of the 31 oxacillin-resistant S. aureus (ORSA) isolates, 16 were susceptible to daptomycin (16/31, 51.6%) according to the breakpoint ≤ 1 μg/ml. All 31 ORSA isolates were susceptible to teicoplanin, and vancomycin but MICs of vancomycin for all 31 ORSA isolates were ≥ 1 μg/ml. Of the 21 isolates of A. baumannii that were multiple-drug-resistant, 19 isolates (19/21, 90%) were susceptible to colistin and 18 isolates (18/21, 86%) sensitive to tigecycline. Of the 22 isolates of E. coli with extended-spectrum beta-lactamase (ESBL), the most susceptible antimicrobial agent were colistin (20/22, 91%), ertapenem (21/22, 96%), meropenem and tigecycline (22/22, 100%). Of the 11 isolates of P. aeruginosa, 6 isolates were susceptible to colistin (6/11, 55%) and all isolates were susceptible to meropenem (11/11, 100%).For nosocomial infections caused by MDR-Acinetobacter baumannii, colistin and tigecycline are usually susceptible according to the result of this study. For nosocomial infections caused by ORSA, ORSA has reduced susceptibility to vancomycin, teicoplanin and daptomycin. For MDR-P. aeruginosa, further study is needed.
In 2004, there was an AIDS outbreak among Taiwanese injecting drug users (IDUs). A questionnaire on AIDS-related knowledge was thus needed, but the existing questionnaire was outdated. We designed a new questionnaire and evaluated its reliability and validity. Many psychometric properties were evaluated, including expert validity, construct validity for known group difference, item analysis and internal consistency, and test-retest reliability. Study sample were enrolled from school adolescence, drug users arrested by police, IDUs who received MMT, and public health workers. The ratings from 9 content experts were all higher than 3.2 (maximum 5), indicating acceptable content validity. During 2005-2007, 3,130 adolescents, 1,162 arrested drug users, 204 IDUs with MMT, and 116 public health workers completed the questionnaire. Public health workers had the highest rate of correct answers, followed by IDUs with MMT, the arrested drug users and school adolescents implying a good known group difference of construct validity. The difficulty index was within the acceptable range, and the discrimination index was >25%. Cronbach's α was 0.60-0.82, indicating good internal consistency. Regarding test-retest reliability, the correlation coefficient for 83 individuals who completed the questionnaire twice was 0.59, showing good stability over time. Our questionnaire has an acceptable psychometric property, including good expert validity, construct validity and test-retest reliability.
Many of the indices utilized in the assessment of nutritional status are dependent upon stature. Knee height has been used to predict stature in western countries when standing height cannot be measured, however, an adequate stature-knee height equation has not been established for the population in Taiwan.A total of 1179 healthy men (603) and women (576) were recruited from those who had undergone comprehensive check-ups at their own expense from March through August 1998 at Lin-Kou Chang-Gung Memorial Hospital, Taiwan. The subjects were freely ambulatory without kyphosis or scoliosis noted on their chest X-ray or KUB films. The automatic supersonic system was used to measure stature and body weight. A Ross caliper was used to measure recumbent left knee height. Multiple linear regression was used to obtain equations to estimate stature using knee height and age.Stature of adults highly correlated with their knee height (r = 0.73 with 95%CI between 0.69 and 0.77 for men, and r = 0.68 with 95%CI between 0.63 and 0.72 for women) but declined with age (men: r = -0.17 with 95%CI between -0.09 and -0.24; women: r = -0.22 with 95%CI between -0.14 and -0.29). Knee height changed very little with age in both genders. To predict stature, a linear regression model should include knee height and age as predictors to reach r2 as 0.61 and 0.58 for men and women, respectively. The stature-knee height equations were "stature = 85.10 + 1.73 x knee height -0.11 x age" for men, "stature = 91.45 + 1.53 x knee height -0.16 x age" for women.Our stature-knee height equations provided good predictions on stature of adult population in Taiwan, and was superior when compared with equations developed from other populations.
Premarital health examination (PHE) is ideally to prevent sexually-transmitted diseases (STD) within a couple; to detect reproductive problems or hereditary illness which may pass to offspring; and to provide counseling on family planning and genetic health.However, little is known about the implementation of PHE program.We conducted a selfadministered questionnaire survey to participants who took PHE in Taoyuan, Taiwan.An importance-performance analysis (IPA) was made to identify which service attributes of PHE program should be improved.Test items and cost of PHE were obtained from the hospitals studied.A total of 336 participants were recruited in 2005.About one-third took PHE after marriage.Only a few PHE programs included screening for reproductive problems (such as semen analysis) or hereditary diseases.Most underwent examinations because of concerns over their own health, reproductive worry, genetic reason and family planning.IPA revealed that the competitive vulnerability (high expectation but low satisfaction) of PHE was unsatisfactory in regard to the examination reports and suggestions regarding genetic health and family planning.Preventing STD transmission within a couple, a function of PHE, is challenged as it is common for couples to have sexual intercourse before marriage and extramarital sexual relationships are common in some places.Without screening for reproductive problems or hereditary illnesses, PHEs are no different from general physical examinations.The couples' desires for information related to reproductive concern, care for their own health, and family planning were not fulfilled.How PHE program implement in Taiwan is recommended.
In 2003, nosocomial infections caused by vancomycin-resistant enterococci (VRE) occurred rarely in Taiwan. Between 2003 and 2010, however, the average prevalence of vancomycin resistance among enterococci spp. increased from 2% to 16% in community hospitals and from 3% to 21% in medical centers of Taiwan. We used molecular methods to investigate the epidemiology of VRE in a tertiary teaching hospital in Taiwan. Between February 2009 and February 2011, rectal samples and infection site specimens were collected from all inpatients in the nephrology ward after patient consent was obtained. VRE strain types were determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). A total of 59 vanA gene-containing VRE isolates (1 per patient) were obtained; 24 originated from rectal sample surveillance of patients who exhibited no symptoms (22 Enterococcus faecium and 2 Enterococcus faecalis), and 35 had developed infections over 3 days after admission (32 E. faecium, 2 E. faecalis, and 1 Enterococcus durans). The 59 VRE isolates demonstrated vancomycin minimum inhibitory concentrations (MICs) of ≥256 μg/m. The MIC range for linezolid, tigecycline, and daptomycin was 0.25–1.5 μg/mL, 0.032–0.25 and 1–4 μg/mL, respectively. For 56 isolates, the MIC for teicoplanin was >8 μg/mL. The predominant types in the nephrology ward were MLST types 414, 78, and18 as well as PFGE types A, C, and D. VREs are endemic in nephrology wards. MLST 414 is the most predominant strain. The increase VRE prevalence is due to cross-transmission of VRE clones ST 414,78,18 by undetected VRE carriers. Because similar VRE STs had been reported in a different hospital of Taiwan, this finding may indicate inter-hospital VRE spread in Taiwan. Active surveillance and effective infection control policies are important controlling the spread of VRE in high risk hospital zones. All endemic VRE strains are resistant to teicoplanin but are sensitive to daptomycin, linezolid, and tigecycline.
The heritability of atrial fibrillation (AF), the contribution of genetic and environmental factors, and the association of a family history of AF with prognosis are unclear.
Objectives
To measure genetic and environmental factors in the familial aggregation of AF and to estimate the association of a family history of AF with major adverse cardiovascular events (MACE).
Design, Setting, and Participants
In this Taiwanese nationwide population-based study among more than 23 million people, a custom data set was obtained using the data of all patients having a diagnosis of AF recorded between January 1996 and December 2013 in the Taiwan National Health Insurance Research Database. The study population comprised all 23 422 955 individuals registered with the database in 2013, of whom 177 770 had a diagnosis of AF and were included in the heritability estimation. From the latter, a subgroup of patients having newly diagnosed AF with a first-degree relative affected by AF between 2000 and 2010 were selected and matched 1:4 to controls without a family history for estimating MACE-free survival. The dates of analysis were January 2010 to December 2013.
Main Outcomes and Measures
The prevalence and relative risk of AF in relatives of patients with AF, as well as the relative contributions of heritability and shared and nonshared environmental factors to AF susceptibility. Also measured was MACE-free survival after AF was diagnosed.
Results
In total, 1510 patients (204 [13.5%] female; mean [SD] age, 57.9 [9.2] years) had newly diagnosed AF with a first-degree relative affected by AF. Individuals with a first-degree relative affected by AF had a relative risk of 1.92 (95% CI, 1.84-1.99) for AF. The accountability for the phenotypic variance of AF was 19.9% for genetic factors (heritability), 3.5% for shared environmental factors, and 76.6% for nonshared environmental factors. After matching for age, sex, hypertension, type 2 diabetes, previous stroke, and anticoagulation, incident AF patients with vs without an affected first-degree relative had similar MACE-free survival.
Conclusions and Relevance
Genetic and environmental factors were associated with AF, with nonshared environmental factors accounting for three-fourths of the phenotypic variance in Taiwan. Patients having AF with a first-degree relative affected by AF did not have more MACE. Therefore, family history may not be particularly informative in the diagnosis or management of AF.